Haojie Jin

机构：Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, State Key Laboratory of Oncogene and Related Genes, Zhejiang University of Technology · ORCID：0000-0001-9295-1951

发表论文 157 篇 · 总被引 7213 次 · h-index 37

代表论文

• Prognostic implications of adverse events associated with CAR-T cell therapy: a population-based global observational study (2025 · EClinicalMedicine · 被引 2)
• Sesaminol Ameliorates Metabolic and Alcohol‐Related Liver Injury by Activating the PPARα/Slc27a5 Axis‐Driven Hepatic Fatty Acid β‐Oxidation (2026 · Molecular Nutrition & Food Research · 被引 1)
• Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D (2025 · Cell Reports · 被引 1)
• Personalized management of metabolic dysfunction-associated steatotic liver disease (2025 · iLiver · 被引 1)
• H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamics (2026 · Science Advances)
• Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm (2026 · Hepatology Communications)